Effects of Mother Position in Skin-to-skin Contact Newborn on Oxygen Saturation Levels.
NCT ID: NCT02585492
Last Updated: 2018-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1243 participants
INTERVENTIONAL
2015-11-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Delivery Room Skin-to-skin Study
NCT01959737
Air vs. Cutaneous Control Mode for Preterm Infants ≤ 32 WG in Incubators: Impact on Body Growth and Morbidity
NCT03919188
Is Skin-to-Skin Care Helpful for Preterm Infants and Their Mothers After Birth?
NCT00917085
Prone or Supine Effect After Caesarean Delivery on Respiratory Outcomes in Full Term Infants
NCT02692573
Skin-to-skin Contact During the Transfer From the Delivery Room to the Neonatal Intensive Care Unit: Impact on Very Preterm Infants and Their Parents
NCT05820386
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators's hypothesis is that the frequency of episodes of oxygen saturation less than 91% in the first 2 hours of life of the newborn is reduced by one third in children whose mothers are incorporated at 45° above the horizontal plane of the bed compared with children whose mothers are incorporated to 15º.
This is a multicenter, randomized and controlled study in 10 Spanish hospitals with blind evaluation. 5866 participants will be enrolled in this study (a total of 1275 children are required in each arm of the study).
Mother/child (defined as a dyad) will be randomized in two groups:
Group A: head-of-bed elevated 15°. Group B: head-of-bed elevated 45°.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
head-of-bed elevated 15°
Mother's head-of-bead elevated 15°. Intervention: Head-of-bed elevated 15° during 2 hours after the delivery.
Head-of-bed elevated 15°
Head-of-bed elevated 15° during 2 hours after delivery.
head-of-bed elevated 45°
Mother's head-of-bead elevated 45°. Intervention: Head-of-bed elevated 45°during 2 hours after delivery.
Head-of-bed elevated 45°
Head-of-bed elevated 45° during 2 hours after delivery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Head-of-bed elevated 15°
Head-of-bed elevated 15° during 2 hours after delivery.
Head-of-bed elevated 45°
Head-of-bed elevated 45° during 2 hours after delivery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Pregnancy controlled or partially controlled(1)
3. Normal pregnancy or with gestational diabetes treated with diet, high blood pressure controlled with only a drug as maximum (without preeclampsia)
4. Gestation to term (between 37 weeks to 41 weeks and 6 days of gestational age).
5. Maternal temperature at onset of labor ≤38 degrees Celsius
6. Presence of a companion during the 2 hours after delivery
7. Desire of the mother to perform early skin-to-skin
Exclusion Criteria
2. Prenatal diagnosis of chromosomal abnormalities or major malformations.
3. Prenatal diagnosis of intrauterine growth restriction with any degree of alteration in the flow as well as the abnormal small-for-gestational-age fetuses (due to malformations, intrauterine infection ...).
4. No companion during the first two hours postpartum
Notes:
1. Partially controlled pregnancy: she has the 20 weeks ultrasound but lack the first and/or third trimester of pregnancy and/or analytical (serology, O'Sullivan test ...).
2. Medicinal products with sedative or relaxing effect: opioids, anticonvulsants, antipsychotics, benzodiazepines, anxiolytics, hypnotics, antidepressants and sedative plants.
1. Related to childbirth:
* Caesarean section or instrumental delivery (forceps, vacuum)
* Maternal fever \>38 degrees Celsius
* Mother hemodynamic instability (hypotension, tachycardia, altered level of consciousness, poor perfusion, striking pallor)
* Cord prolapse
* Signs of fetal distress with lower pH fetal scalp \<7.25 or umbilical artery pH \<7.20
* Any other obstetrical complication
2. Related mother:
* Any type of illness
* Sedatives or relaxants during or after birth(3)
3. Related Newborn (RN)
* Need for resuscitation measures
* Major malformation diagnosed intrapartum
* Apgar ≤7 at one minute, 5 or 10 minutes
* Presence of clinic(4) before the 10 minutes of life
* Birth weight \<2300 g or\>4500 g
4. Interruption of skin contact because the mother present a problem
Notes:
(3) Sedatives or relaxants during or after birth: Pethidine (Dolantina®), scopolamine (Buscapina®), haloperidol, benzodiazepines and opiates.
(4) Clinic: general discomfort, fever, hypothermia, pallor, mottled skin (cutis marmorata), cyanosis, petechiae, purpura, lethargy, weakness, poor responsiveness, seizures, tremors, poor perfusion, maintained tachycardia, bradycardia, hypotension, apnea, tachypnea, respiratory distress (grunting, nasal flaring, intercostal or subcostal or substernal retractions, thoracoabdominal dissociation), vomiting, abdominal distesion, etc.
Clarifications:
It can include:
1. Newborns with intrauterine diagnosis of ectasia pyelocaliceal grades I and/or II, choroid plexus cysts, aberrant right subclavian artery or single umbilical artery (minor malformations).
2. Newborns whose time broken bag is ≥ to 18 hours provided that they do not present clinic(4).
3. Newborn with risk of infection without symptoms at birth.
4. Newborn with stained amniotic fluid, born crying, who does not require tracheal aspiration, or resuscitation and shows no clinical(4) signs during the first 10 minutes after birth.
5. Small for normal fetal gestational age (genetic-family origin)
259 Days
293 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario 12 de Octubre
OTHER
Red Salud Materno Infantil y del Desarrollo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadia R. García Lara, Dra
Role: STUDY_CHAIR
Hospital Universitario 12 de Octubre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Severo Ochoa
Leganés, Madrid, Spain
Hospital Universitario de Cruces
Bilbao, Vizcaya, Spain
Hospital de Vielha
Lleida, , Spain
Hospital Universitario 12 de Octubre
Madrid, , Spain
Hospital Universitario La Paz
Madrid, , Spain
Hospital Universitario Quirón
Madrid, , Spain
Hospital La Fe
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rodriguez Lopez J, Garcia Lara NR, Lopez Maestro M, De la Cruz Bertolo J, Martinez Avila JC, Vento M, Parra Llorca A, Izquierdo Macian I, Pellicer A, Marin Huarte N, Asla Elorriaga I, Roman Echevarria L, Copons Fernandez C, Martin Ancel A, Cabanas F, Garcia Algar O, Pallas Alonso CR. What is the impact of mother's bed incline on episodes of decreased oxygen saturation in healthy newborns in skin-to-skin contact after delivery: Study protocol for a randomized controlled trial. Trials. 2019 Mar 20;20(1):179. doi: 10.1186/s13063-019-3256-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Neonatologia-2014-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.